AngioDynamics Inc (ANGO)
6.95
+0.21
(+3.12%)
USD |
NASDAQ |
Nov 21, 16:00
6.95
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Net Income (Quarterly): -12.80M for Aug. 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | -12.80M |
| May 31, 2024 | -13.45M |
| February 29, 2024 | -187.74M |
| November 30, 2023 | -29.05M |
| August 31, 2023 | 45.88M |
| May 31, 2023 | -21.47M |
| February 28, 2023 | -9.485M |
| November 30, 2022 | -8.486M |
| August 31, 2022 | -13.00M |
| May 31, 2022 | -6.266M |
| February 28, 2022 | -4.958M |
| November 30, 2021 | -8.351M |
| August 31, 2021 | -6.972M |
| May 31, 2021 | -19.47M |
| February 28, 2021 | -3.544M |
| November 30, 2020 | -4.268M |
| August 31, 2020 | -4.268M |
| May 31, 2020 | -157.07M |
| February 29, 2020 | -5.709M |
| November 30, 2019 | -2.736M |
| August 31, 2019 | -1.275M |
| May 31, 2019 | 58.87M |
| February 28, 2019 | 0.796M |
| November 30, 2018 | 2.14M |
| August 31, 2018 | -0.469M |
| Date | Value |
|---|---|
| May 31, 2018 | 2.102M |
| February 28, 2018 | 14.02M |
| November 30, 2017 | 0.249M |
| August 31, 2017 | -0.035M |
| May 31, 2017 | -24.97M |
| February 28, 2017 | 2.887M |
| November 30, 2016 | 13.73M |
| August 31, 2016 | 1.30M |
| May 31, 2016 | -43.08M |
| February 29, 2016 | 0.594M |
| November 30, 2015 | -0.334M |
| August 31, 2015 | -0.775M |
| May 31, 2015 | -0.934M |
| February 28, 2015 | -4.262M |
| November 30, 2014 | 1.338M |
| August 31, 2014 | 0.47M |
| May 31, 2014 | -1.534M |
| February 28, 2014 | 4.515M |
| November 30, 2013 | -0.261M |
| August 31, 2013 | -0.373M |
| May 31, 2013 | -1.467M |
| February 28, 2013 | -0.992M |
| November 30, 2012 | 1.969M |
| August 31, 2012 | -0.721M |
| May 31, 2012 | -7.117M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-187.74M
Minimum
Feb 2024
45.88M
Maximum
Aug 2023
-23.66M
Average
-8.418M
Median
Net Income (Quarterly) Benchmarks
| Globus Medical Inc | 51.84M |
| Perspective Therapeutics Inc | -15.12M |
| Retractable Technologies Inc | -1.922M |
| Xtant Medical Holdings Inc | -5.024M |
| Catheter Precision Inc | -4.12M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 67.49M |
| Total Expenses (Quarterly) | 76.20M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 223.67M |
| Gross Profit Margin (Quarterly) | 54.41% |
| Profit Margin (Quarterly) | -18.96% |
| Earnings Yield | -86.76% |
| Normalized Earnings Yield | -17.50 |